Interacting Drugs |
Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine vs Sulfonamide Derivatives |
Security Level |
 |
Mechanism |
Sulfonamide Derivatives: Methenamine may enhance the adverse/toxic effect of Sulfonamide Derivatives. Specifically, the combination may result in the formation of an insoluble precipitate in the urine. |
Management |
Avoid combination |
Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine vs Sulfonamide Derivatives
Post Review about Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine vs Sulfonamide Derivatives Click here to cancel reply.
Other Interactions of Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine
Other Interactions of Sulfonamide Derivatives
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.